Doripenem Pharmacokinetics in Critically Ill Patients Receiving Continuous Hemodiafiltration (CHDF)

Doripenem Pharmacokinetics in Critically Ill Patients Receiving Continuous Hemodiafiltration (CHDF)

Objectives of the prospective, open-label study were to investigate pharmacokinetics of doripenem and determine appropriate doripenem regimens during continuous hemodiafiltration (CHDF) in critically ill patients with renal failure (creatinine clearance

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:YAKUGAKU ZASSHI 2010/01/01, Vol.130(1), pp.87-94
Hauptverfasser: HIDAKA, Seigo, GOTO, Koji, HAGIWARA, Satoshi, IWASAKA, Hideo, NOGUCHI, Takayuki
Format: Artikel
Sprache:eng
Schlagworte:
acute renal failure
Aged
Aged, 80 and over
antibiotic
Carbapenems - administration & dosage
Carbapenems - blood
Carbapenems - pharmacokinetics
Critical Illness
Doripenem
Female
Half-Life
Hemodiafiltration
Humans
Male
Metabolic Clearance Rate
Middle Aged
pharmacology
Prospective Studies
Renal Insufficiency - metabolism
Renal Insufficiency - therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives of the prospective, open-label study were to investigate pharmacokinetics of doripenem and determine appropriate doripenem regimens during continuous hemodiafiltration (CHDF) in critically ill patients with renal failure (creatinine clearance
ISSN:0031-6903
1347-5231
DOI:10.1248/yakushi.130.87